This episode examines Hyphens Pharma International's recent performance and its strategic shift amidst regional headwinds. We explore how the company balances significant challenges in one major market with the robust growth of its own proprietary labels.

• The Regional Hurdle: Discover how shifting dynamics and currency volatility in Vietnam are impacting the group's core pharmaceutical segment

• Global Expansion: Learn how new international licensing deals and dermatologist-backed product launches are opening doors beyond Southeast Asia

• Looking Ahead: We analyze the regulatory milestones and portfolio adjustments that could signal a future normalization of profitability